DermTech, Inc. (DMTKQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Dec 26, 2024, 3:00 PM EST
DermTech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 15.66 | 15.3 | 14.52 | 11.84 | 5.89 | 3.36 | Upgrade
|
| Revenue Growth (YoY) | 9.71% | 5.36% | 22.64% | 101.16% | 74.94% | 37.76% | Upgrade
|
| Cost of Revenue | 14.33 | 15.02 | 13.87 | 10.56 | 5.98 | 3.3 | Upgrade
|
| Gross Profit | 1.33 | 0.28 | 0.65 | 1.27 | -0.1 | 0.06 | Upgrade
|
| Selling, General & Admin | 73.74 | 83.08 | 94.76 | 62.41 | 29.9 | 15.17 | Upgrade
|
| Research & Development | 14.1 | 15.24 | 24.05 | 16.26 | 5.29 | 2.5 | Upgrade
|
| Operating Expenses | 87.84 | 98.32 | 118.81 | 78.67 | 35.19 | 17.67 | Upgrade
|
| Operating Income | -86.5 | -98.04 | -118.17 | -77.4 | -35.29 | -17.61 | Upgrade
|
| Interest Expense | -0.01 | -0.01 | -0.01 | -0.02 | -0 | -2.66 | Upgrade
|
| Interest & Investment Income | 2.57 | 2.85 | 1.35 | 0.17 | 0.04 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | 0.01 | 0.14 | -1.09 | -1.23 | -0.8 | Upgrade
|
| EBT Excluding Unusual Items | -83.93 | -95.19 | -116.68 | -78.34 | -36.48 | -21.06 | Upgrade
|
| Merger & Restructuring Charges | -2.1 | -2.1 | - | - | - | - | Upgrade
|
| Other Unusual Items | -3.6 | -3.6 | - | - | - | 0.93 | Upgrade
|
| Pretax Income | -89.63 | -100.89 | -116.68 | -78.34 | -36.48 | -20.13 | Upgrade
|
| Earnings From Continuing Operations | - | -100.89 | -116.68 | -78.34 | -36.48 | -20.13 | Upgrade
|
| Net Income | -89.63 | -100.89 | -116.68 | -78.34 | -36.48 | -20.13 | Upgrade
|
| Net Income to Common | -89.63 | -100.89 | -116.68 | -78.34 | -36.48 | -20.13 | Upgrade
|
| Shares Outstanding (Basic) | 34 | 33 | 30 | 29 | 17 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 34 | 33 | 30 | 29 | 17 | 7 | Upgrade
|
| Shares Change (YoY) | 11.45% | 8.66% | 4.00% | 70.12% | 142.39% | 58.81% | Upgrade
|
| EPS (Basic) | -2.66 | -3.09 | -3.88 | -2.71 | -2.15 | -2.87 | Upgrade
|
| EPS (Diluted) | -2.67 | -3.09 | -3.88 | -2.71 | -2.15 | -2.87 | Upgrade
|
| Free Cash Flow | -72.22 | -77.88 | -98.57 | -64.83 | -30.52 | -18 | Upgrade
|
| Free Cash Flow Per Share | -2.14 | -2.39 | -3.28 | -2.24 | -1.80 | -2.57 | Upgrade
|
| Gross Margin | 8.51% | 1.80% | 4.46% | 10.76% | -1.63% | 1.78% | Upgrade
|
| Operating Margin | -552.23% | -640.95% | -813.92% | -653.81% | -599.64% | -523.34% | Upgrade
|
| Profit Margin | -572.19% | -659.57% | -803.71% | -661.72% | -619.83% | -598.39% | Upgrade
|
| Free Cash Flow Margin | -461.03% | -509.16% | -678.92% | -547.61% | -518.57% | -535.11% | Upgrade
|
| EBITDA | -84.65 | -96.22 | -116.53 | -76.4 | -34.8 | -17.52 | Upgrade
|
| D&A For EBITDA | 1.85 | 1.82 | 1.63 | 1 | 0.49 | 0.09 | Upgrade
|
| EBIT | -86.5 | -98.04 | -118.17 | -77.4 | -35.29 | -17.61 | Upgrade
|
| Revenue as Reported | 15.66 | 15.3 | 14.52 | 11.84 | 5.89 | 3.36 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.